Navigation Links
Gene discovery could lead to better soybean varieties for Northern United States
Date:7/15/2014

WEST LAFAYETTE, Ind. Researchers from Purdue University and the University of Nebraska-Lincoln have discovered a soybean gene whose mutation affects plant stem growth, a finding that could lead to the development of improved soybean cultivars for the northern United States.

Purdue agronomy professor Jianxin Ma (pronounced Jen-SHIN' Ma) and collaborators identified a gene known as Dt2, which causes semideterminacy in soybean plants. Semideterminate soybean plants - mid-size plants that continue vegetative growth even after flowering - can produce as many or more pods than current northern cultivars but do not grow as tall. Their reduced height makes them more resistant to lodging, a bending or breaking of the main plant stem.

"This gene could help us improve the yield potential and adaptability of soybeans for specific growing areas," Ma said. "We can now focus on developing a variety of elite semideterminate soybean cultivars, which could perform very well in high-yielding, irrigated environments such as Nebraska and northeastern Indiana."

Soybean cultivars are often divided into two groups: indeterminate - tall plants whose main stem continues to grow after flowering - and determinate - shorter, bushier plants whose main stem halts growth when blossoms begin to form.

Determinate soybean plants thrive in the longer growing season of the south while indeterminate plants' overlapping vegetative and reproductive stages make them better suited to the north. But the height of indeterminate cultivars renders them prone to lodging.

For northern soybean producers, semideterminate soybean plants could represent a "Goldilocks" cultivar, a "just right" alternative between the two. Semideterminate soybeans are easy to manage, have similar or better yields than indeterminate plants and can handle a short growing season, Ma said.

Only one semideterminate soybean cultivar, NE3001, is common in the United States. Having pinpointed Dt2 will enable Ma and his researchers to use natural plant breeding methods to develop a variety of semi-determinate cultivars.

"The potential for soybean yield productivity in the U.S. has not been fully explored, in part because of the lack of semideterminate cultivars," he said. "We're now working on converting high-yielding indeterminate cultivars to semideterminate types to test their yield potential."

Ma - who had previously identified Dt1, the gene that causes indeterminancy in soybeans - used an integrated genetic approach to isolate and characterize Dt2. After identifying the gene, he inserted it into indeterminate cultivars to confirm that it caused the plants to become semideterminate. Dt2 suppresses the expression level of Dt1, causing soybean plants to grow shorter.

Ma said this type of mutation appears to be unique to soybeans as semideterminancy in other plants such as tomatoes and chickpeas is caused by a different genetic mechanism.

Study co-author James Specht, a professor of agronomy and horticulture at the University of Nebraska-Lincoln, said the identification of Dt2 gives soybean breeders a powerful tool for breeding new cultivars.

"This provides breeders with a perfect genetic marker for identifying semideterminancy in soybean seeds and seedlings," he said.


'/>"/>

Contact: Natalie van Hoose
nvanhoos@purdue.edu
765-496-2050
Purdue University
Source:Eurekalert  

Related biology news :

1. Discovery provides insights on how plants respond to elevated CO2 levels
2. New discovery in living cell signaling
3. Discovery of Earths northernmost perennial spring
4. Discovery of a bud-break gene could lead to trees adapted for a changing climate
5. The transmission of information via proteins could revolutionize drug discovery
6. Scientists weed out pesky poison ivy with discovery of killer fungus
7. Amber discovery indicates Lyme disease is older than human race
8. Promising discovery in the fight against antibiotic-resistant bacteria
9. New discovery: Molecule links asthma and cancer and could aid in developing new treatments
10. Scientists at the UA make critical end-stage liver disease discovery
11. Autism Genome Project delivers genetic discovery
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Gene discovery could lead to better soybean varieties for Northern United States
(Date:6/2/2016)... The Department of Transport Management (DOTM) ... million US Dollar project, for the , Supply ... Enrolment, and IT Infrastructure , to ... implementation of Identity Management Solutions. Numerous renowned international vendors participated ... was selected for the most compliant and innovative ...
(Date:6/2/2016)... 2016 Perimeter Surveillance & Detection ... Physical Infrastructure, Support & Other Service  The ... offers comprehensive analysis of the global Border Security ... revenues of $17.98 billion in 2016. Now: ... leader in software and hardware technologies for advanced video ...
(Date:5/24/2016)... IRVINE, Calif. , May 24, 2016 Ampronix facilitates superior patient care ... LMD3251MT  3D medical LCD display is the latest premium product recently added to ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... MONICA, Calif. , June 23, 2016  The Prostate Cancer Foundation ... pioneer increasingly precise treatments and faster cures for prostate cancer. Members of the ... institutions across 15 countries. Read More About the Class ... ... ...
(Date:6/23/2016)... , June 23, 2016   EpiBiome , a ... $1 million in debt financing from Silicon Valley Bank ... automation and to advance its drug development efforts, as ... facility. "SVB has been an incredible strategic ... services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... OTTAWA, ON (PRWEB) , ... June 23, 2016 , ... ... former DNA Technical Leader at the Arkansas State Crime Laboratory, has joined STACS DNA ... joining the STACS DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. ...
(Date:6/23/2016)... , June 23, 2016 Apellis Pharmaceuticals, ... 1 clinical trials of its complement C3 inhibitor, ... and multiple ascending dose studies designed to assess ... of subcutaneous injection in healthy adult volunteers. ... either as a single dose (ranging from 45 ...
Breaking Biology Technology: